Inventor
Rita Dost
Inventor
Dresden, DE
Overview
Patents· 9 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations39%
A61KPreparations for medical, dental or toiletry purposes30%
C07DHeterocyclic compounds30%
PatentTitleYear
10,323,021Triazoles as NR2B receptor inhibitors201910,155,727Pyrazoles20189,981,950Triazoles as NR2B receptor inhibitors20189,540,379'(1,2,4)triazolo[4,3-A]quinoxaline derivatives as inhibitors of phosphodiesterases'20179,469,611'Use of dihydroimidazolones for the treatment of dogs'20168,962,617'Use of dihydroimidazolones for the treatment of dogs'20158,859,540'Use of dihydroimidazolones for the treatment of dogs'20146,117,900'Use of retigabine for the treatment of neuropathic pain'20005,994,347'For a process for treatment of anxiety and tension'1999Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1999–2019Based in Dresden, DE· patent location history
2014–2017Patents assigned to DOST RITA (3)· patent assignee history
2014–2017Patents assigned to LANKAU HANS-JOACHIM (3)· patent assignee history
2014–2015Patents assigned to BOEHRINGER INGELHEIM VETMED (2)· patent assignee history
2014–2015Patents assigned to LOSCHER WOLFGANG (2)· patent assignee history
2018–2019Patents assigned to JANSSEN PHARMACEUTICALS INC (3)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| DOST RITAself | 3 | 2014–2017 |
| JANSSEN PHARMACEUTICALS INC | 3 | 2018–2019 |
| LANKAU HANS-JOACHIM | 3 | 2014–2017 |
| BOEHRINGER INGELHEIM VETMED | 2 | 2014–2015 |
| LOSCHER WOLFGANG | 2 | 2014–2015 |
Locations
| Location | Patents | Span |
|---|---|---|
| Dresden, DE | 9 | 1999–2019 |